HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chattem Launching ACT, Icy Hot Line Extensions, Raises Guidance

This article was originally published in The Tan Sheet

Executive Summary

Chattem says planned launches of line extensions for ACT,Icy Hot and other products in part prompted it to set its fiscal 2009 guidance at 60 cents to 75 cents per share above its 2008 guidance

You may also be interested in...



Chattem Includes Technology, Licensing Deals As Expansion Options

Chattem is ready to pursue technology acquisitions or licensing deals within health and beauty, and likely will make a move within the next few years, according to CEO Zan Guerry

Chattem Relies On Line Extensions To Turn Icy Sales Hot

Consumer health care products firm Chattem says it hopes aggressive support of several product launches, including Icy Hot line extensions, will shake off the effects of a disappointing first quarter

ThermaCare sale a wrap

Wyeth Consumer Healthcare owns the heat wrap ThermaCare after closing the acquisition for an undisclosed amount from Procter & Gamble Sept. 2. Wyeth previously said it sees "tremendous synergy between ThermaCare and Advil," and "significant growth potential" in the heat wrap (1"The Tan Sheet" July 21, 2008, p. 8)

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS137577

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel